INFARMEX JARGAN-SZKLORZ SPÓŁKA JAWNA

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

15/07/2008

VAT status

Active

Bankruptcy proceedings

No proceedings

INFARMEX JARGAN-SZKLORZ SPÓŁKA JAWNA

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

23/12/2016

Share capital

No data

Primary activity

Dispensing chemist in specialized stores (47.73.Z - PKD 2007)

Representatives

Representatives rights

UPRAWNIONE DO REPREZENTACJI SĄ JOLANTA JARGAN I KATARZYNA SZKLORZ DZIAŁAJĄCE SAMODZIELNIE.

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

2,397,859

Net Profit (zł)

2,397,859

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2021
12,348,080
2,172,515
2,172,515
0.26
8.59
17.59
3,294,515
418,719
0
116,131

2023
22,144,624
3,815,903
3,815,903
0.22
11.33
17.23
4,937,903
469,810
0
85,827

2024
15,592,869
2,397,859
2,397,859
0.22
7.16
15.38
3,519,859
561,016
0
65,625

2024
15,592,869
2,397,859
2,397,859
0.22
7.16
15.38
3,519,859
561,016
0
65,625

Turnover (zł)

2024

Turnover (zł)

15,592,869 zł-30 % *

Profit before tax (zł)

2,397,859 zł-37 % *

Net Profit (zł)

2,397,859 zł-37 % *

Working capital requirement (%)

0.22 0.00 % *

Liquidity ratio

7.16 -36.80 % *

Net profitability (%)

15.38 %-10.74 % *

Equity (zł)

3,519,859 zł-29 % *

Current liabilities (zł)

561,016 zł19 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

65,625 zł-24 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

INFARMEX JARGAN-SZKLORZ SPÓŁKA JAWNA Documents

Date	Description
10/10/2024	OD 01.07.2023 DO 30.06.2024
13/10/2023	OD 01.01.2022 DO 30.06.2023
06/10/2022	OD 01.01.2021 DO 31.12.2021
15/07/2021	OD 01.01.2020 DO 31.12.2020
11/09/2020	OD 01.01.2019 DO 31.12.2019